$NVCR
NovoCure Ltd Stock $nvcr

$nvcr Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000164511323000037 Filed on May 04, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$126.1M	$122.2M
YoY Change	-10.52%	-11.17%
Cost Of Revenue	$34.02M	$29.61M
YoY Change	19.35%	6.81%
Gross Profit	$92.03M	$92.57M
YoY Change	-18.09%	-15.71%
Gross Profit Margin	73.01%	75.76%
Selling, General & Admin	$99.27M	$93.11M
YoY Change	29.9%	36.15%
% of Gross Profit	107.86%	100.59%
Research & Development	$55.43M	$59.70M
YoY Change	-2.89%	41.36%
% of Gross Profit	60.23%	64.5%
Depreciation & Amortization	$2.721M	$2.722M
YoY Change	2.52%	4.29%
% of Gross Profit	2.96%	2.94%
Operating Expenses	$154.7M	$152.8M
YoY Change	15.88%	38.14%
Operating Profit	-$62.66M	-$60.25M
YoY Change	196.57%	7375.06%
Interest Expense	$8.756M	$9.169M
YoY Change	-493.0%	-636.51%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$53.90M	-$51.08M
YoY Change	130.79%	1931.01%
Income Tax	$3.514M	$1.981M
% Of Pretax Income
Net Earnings	-$57.42M	-$53.06M
YoY Change	139.16%	1041.83%
Net Earnings / Revenue	-45.55%	-43.43%
Basic Earnings Per Share	-$0.54	-$0.50
Diluted Earnings Per Share	-$0.54	-$0.50
COMMON SHARES
Basic Shares Outstanding	106.2M shares	105.5M shares
Diluted Shares Outstanding	106.3M shares	105.7M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$940.8M	$958.0M
YoY Change	16.48%	2.76%
Cash & Equivalents	$140.0M	$186.0M
Short-Term Investments	$790.8M	$813.8M
Other Short-Term Assets	$516.0K	$676.0K
YoY Change	-99.64%	-23.96%
Inventory	$33.02M	$31.72M
Prepaid Expenses
Receivables	$70.99M	$74.83M
Other Receivables	$20.15M	$23.73M
Total Short-Term Assets	$1.065B	$1.089B
YoY Change	-2.66%	0.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$78.95M	$36.45M
YoY Change	197.25%	45.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$14.57M	$11.15M
YoY Change	33.71%	-5.75%
Total Long-Term Assets	$93.53M	$85.35M
YoY Change	37.3%	22.57%
TOTAL ASSETS
Total Short-Term Assets	$1.065B	$1.089B
Total Long-Term Assets	$93.53M	$85.35M
Total Assets	$1.159B	$1.174B
YoY Change	-0.31%	2.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$82.54M	$81.47M
YoY Change	3.29%	17.75%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$150.1M	$148.8M
YoY Change	10.85%	16.41%
LONG-TERM LIABILITIES
Long-Term Debt	$567.2M	$566.3M
YoY Change	0.59%	0.59%
Other Long-Term Liabilities	$26.10M	$136.0K
YoY Change	10818.41%	-12.82%
Total Long-Term Liabilities	$593.2M	$593.4M
YoY Change	1.31%	1.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$150.1M	$148.8M
Total Long-Term Liabilities	$593.2M	$593.4M
Total Liabilities	$743.3M	$742.2M
YoY Change	3.1%	3.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$888.9M	-$831.5M
YoY Change	24.4%	20.41%
Common Stock	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$415.7M	$432.1M
YoY Change
Total Liabilities & Shareholders Equity	$1.159B	$1.174B
YoY Change	-0.31%	2.1%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$57.42M	-$53.06M
YoY Change	139.16%	1041.83%
Depreciation, Depletion And Amortization	$2.721M	$2.722M
YoY Change	2.52%	4.29%
Cash From Operating Activities	-$22.74M	-$16.73M
YoY Change	-244.25%	353.68%
INVESTING ACTIVITIES
Capital Expenditures	$6.931M	$6.088M
YoY Change	67.78%	19.54%
Acquisitions
YoY Change
Other Investing Activities	-$6.966M	$88.38M
YoY Change	-104.36%	-817.5%
Cash From Investing Activities	-$13.90M	$82.29M
YoY Change	-108.92%	-572.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$3.000K	$7.000K
YoY Change	-57.14%	0.0%
Cash From Financing Activities	7.502M	$5.204M
YoY Change	58.4%	65.68%
NET CHANGE
Cash From Operating Activities	-22.74M	-$16.73M
Cash From Investing Activities	-13.90M	$82.29M
Cash From Financing Activities	7.502M	$5.204M
Net Change In Cash	-29.13M	$70.81M
YoY Change	-116.54%	-493.78%
FREE CASH FLOW
Cash From Operating Activities	-$22.74M	-$16.73M
Capital Expenditures	$6.931M	$6.088M
Free Cash Flow	-$29.67M	-$22.82M
YoY Change	-355.08%	159.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001645113
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-37565
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	NovoCure Limited
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	Y9
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1057807
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	No. 4 The Forum
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Grenville Street
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	St. Helier
CY2023Q1	dei	Entity Address Country EntityAddressCountry	JE
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	JE2 4UF
CY2023Q1	dei	City Area Code CityAreaCode	44 (0) 15
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	3475 6700
CY2023Q1	dei	Security12b Title Security12bTitle	Ordinary Shares, no par value
CY2023Q1	dei	Trading Symbol TradingSymbol	NVCR
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	106209251	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	185963000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	115326000	usd
CY2023Q1	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	772072000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	854099000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	676000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	508000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	74830000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	86261000	usd
CY2023Q1	nvcr	Receivables And Prepaid Expenses ReceivablesAndPrepaidExpenses	23730000	usd
CY2022Q4	nvcr	Receivables And Prepaid Expenses ReceivablesAndPrepaidExpenses	25959000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	31723000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	29376000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1088994000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1111529000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36454000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32678000	usd
CY2023Q1	nvcr	Field Equipment Net Noncurrent FieldEquipmentNetNoncurrent	12216000	usd
CY2022Q4	nvcr	Field Equipment Net Noncurrent FieldEquipmentNetNoncurrent	12684000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25529000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	23596000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11147000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11161000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	85346000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	80119000	usd
CY2023Q1	us-gaap	Assets Assets	1174340000	usd
CY2022Q4	us-gaap	Assets Assets	1191648000	usd
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	81469000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	85197000	usd
CY2023Q1	nvcr	Other Accounts Payable Lease Liabilities And Accrued Expenses Current OtherAccountsPayableLeaseLiabilitiesAndAccruedExpensesCurrent	67306000	usd
CY2022Q4	nvcr	Other Accounts Payable Lease Liabilities And Accrued Expenses Current OtherAccountsPayableLeaseLiabilitiesAndAccruedExpensesCurrent	73580000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	148775000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	158777000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	566324000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	565509000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1843000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2878000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	19973000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	18762000	usd
CY2023Q1	nvcr	Employee Related Liabilities Non Current EmployeeRelatedLiabilitiesNonCurrent	5143000	usd
CY2022Q4	nvcr	Employee Related Liabilities Non Current EmployeeRelatedLiabilitiesNonCurrent	4404000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	136000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	148000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	593419000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	591701000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	742194000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	750478000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	106187162	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	106187162	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	105049411	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	105049411	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1266358000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1222063000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2691000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2433000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-831521000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-778460000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	432146000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	441170000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1174340000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1191648000	usd
CY2023Q1	us-gaap	Revenues Revenues	122182000	usd
CY2022Q1	us-gaap	Revenues Revenues	137547000	usd
CY2022	us-gaap	Revenues Revenues	537840000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	29614000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	27727000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	114867000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	92568000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	109820000	usd
CY2022	us-gaap	Gross Profit GrossProfit	422973000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	59704000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	42234000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	206085000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	51169000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	37884000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	173658000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	41944000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30508000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	132753000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	152817000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	110626000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	512496000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-60249000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-806000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-89523000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	9169000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1709000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	7677000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-51080000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2515000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-81846000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1981000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2132000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10688000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-53061000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4647000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-92534000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.88
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105667072	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104186120	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104660476	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.88
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105667072	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104186120	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104660476	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-53061000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4647000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-92534000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	300000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	330000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1425000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	357000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-445000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	915000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1511000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	244000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-53319000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2806000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-91798000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	441170000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	39084000	usd
CY2023Q1	nvcr	Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures	5211000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-258000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-53061000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	432146000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	410494000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	25045000	usd
CY2022Q1	nvcr	Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures	3148000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1841000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4647000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	435881000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-53061000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4647000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-92534000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2722000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2610000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10624000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1120000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-221000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2216000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	126000	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	135000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	955000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	39084000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	25045000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	106955000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	127000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-249000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3256000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-14511000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7461000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2547000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-4056000	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	684000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	-1536000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2718000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4804000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4342000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1534000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1863000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-7107000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-10464000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-14809000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	14257000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-3158000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2331000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-7773000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16727000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3687000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	30788000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6088000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5093000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21358000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	326287000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	279000000	usd
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	1179289000	usd
CY2023Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	237912000	usd
CY2022Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	291317000	usd
CY2022	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	1297888000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	82287000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17410000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-139957000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5224000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	28000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5211000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3148000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10295000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5204000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3141000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15491000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-25000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-97000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	70805000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-17981000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-93775000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115834000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	209609000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	209609000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	186639000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	191628000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115834000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1712000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1173000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5480000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	41000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3451000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3580000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	12117000	usd
CY2023Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	517993000	usd
CY2023Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	1673000	usd
CY2023Q1	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	1467000	usd
CY2023Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	518199000	usd
CY2023Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	517993000	usd
CY2023Q1	nvcr	Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities Amortized Cost CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecuritiesAmortizedCost	958035000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain	1673000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Loss DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss	1467000	usd
CY2023Q1	nvcr	Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities Fair Value CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecuritiesFairValue	958241000	usd
CY2023Q1	nvcr	Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecurities	958035000	usd
CY2022Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	537153000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	1086000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	1139000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	537100000	usd
CY2022Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	537153000	usd
CY2022Q4	nvcr	Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities Amortized Cost CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecuritiesAmortizedCost	969425000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain	1086000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Loss DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss	1139000	usd
CY2022Q4	nvcr	Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities Fair Value CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecuritiesFairValue	969372000	usd
CY2022Q4	nvcr	Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecurities	969425000	usd
CY2022Q4	us-gaap	Held To Maturity Securities Transferred Security Unrealized Gain Loss HeldToMaturitySecuritiesTransferredSecurityUnrealizedGainLoss	-911000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	342403000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1467000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	363375000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1139000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4590000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4314000	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9797000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9321000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	17336000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	15741000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	31723000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	29376000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	76.97
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	429752	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.07
CY2023Q1	us-gaap	Deposits Assets DepositsAssets	2341000	usd
CY2022Q4	us-gaap	Deposits Assets DepositsAssets	2296000	usd
CY2023Q1	us-gaap	Contractual Obligation ContractualObligation	2700000	usd
CY2022Q4	us-gaap	Contractual Obligation ContractualObligation	2459000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8786364	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	37.27
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	627764	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	63147	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	96.06
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8921229	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	40.86
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7204441	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	30.28
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	429752	shares
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	39084000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25045000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	106955000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-53061000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4647000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-92534000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105667072	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104186120	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104660476	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105667072	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104186120	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104660476	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7543657	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7874118	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7272606	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.88
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.88
CY2023Q1	us-gaap	Noncurrent Assets NoncurrentAssets	48670000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	45362000	usd
CY2023Q1	us-gaap	Revenues Revenues	122182000	usd
CY2022Q1	us-gaap	Revenues Revenues	137547000	usd
CY2022	us-gaap	Revenues Revenues	537840000	usd

Files In Submission

Name	View Source	Status
nvcr-20230331_cal.xml	Edgar Link	unprocessable
0001645113-23-000037-index-headers.html	Edgar Link	pending
0001645113-23-000037-index.html	Edgar Link	pending
0001645113-23-000037.txt	Edgar Link	pending
0001645113-23-000037-xbrl.zip	Edgar Link	pending
ex1012023q1frankleonardemp.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
nvcr-20230331.htm	Edgar Link	pending
nvcr-20230331.xsd	Edgar Link	pending
nvcr-20230331exx311.htm	Edgar Link	pending
nvcr-20230331xexx312.htm	Edgar Link	pending
nvcr-20230331xexx321.htm	Edgar Link	pending
nvcr-20230331xexx322.htm	Edgar Link	pending
nvcr-20230331_g1.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nvcr-20230331_def.xml	Edgar Link	unprocessable
nvcr-20230331_lab.xml	Edgar Link	unprocessable
nvcr-20230331_pre.xml	Edgar Link	unprocessable
nvcr-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NVCR
NovoCure Ltd Stock $nvcr

2023 Q2 Form 10-Q Financial Statement

#000164511323000037 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVCR NovoCure Ltd Stock $nvcr

2023 Q2 Form 10-Q Financial Statement

#000164511323000037 Filed on May 04, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NVCR
NovoCure Ltd Stock $nvcr